Difference between revisions of "Artificial Intelligence"

From Multiplyd Wiki
Jump to: navigation, search
(Computer Vision)
 
(8 intermediate revisions by the same user not shown)
Line 11: Line 11:
 
*[http://www.precisionhealth.ai/product-and-solution.html Precision Health AI]: $20M Series A in 2017. Oncology treatment focus.
 
*[http://www.precisionhealth.ai/product-and-solution.html Precision Health AI]: $20M Series A in 2017. Oncology treatment focus.
 
*[http://carta.healthcare/ Carta]: ML-based predictive models off of EHR data. Inpatient-focused. Funded by AMV.
 
*[http://carta.healthcare/ Carta]: ML-based predictive models off of EHR data. Inpatient-focused. Funded by AMV.
 +
*[http://www.eko.ai Eko.ai]: Stealth but something around Echocardiograms. Singapore.
  
 
== Computer Vision ==
 
== Computer Vision ==
Line 22: Line 23:
 
*[http://www.qure.ai Qure.ai]: Imaging AI
 
*[http://www.qure.ai Qure.ai]: Imaging AI
 
*[http://www.viz.ai Viz.AI]: AI-based identification of suspected large vessel occlusion (LVO) strokes. $30.6M Series A. KPCB.
 
*[http://www.viz.ai Viz.AI]: AI-based identification of suspected large vessel occlusion (LVO) strokes. $30.6M Series A. KPCB.
*[https://www.arterys.com/ Arterys]: AI for radiology workflow. $46M raised.
+
*[https://www.arterys.com/ Arterys]: AI for radiology workflow. $46M raised. Has FDA approvals.
 +
*[http://www.brainomix.com/ Brainomix]: AI interpretation of brain CT scans of stroke patients. $13M raised. UK based.
 +
*[http://www.md.ai MD.AI]: Annotation tool, algorithms and datasets.
 +
*[http://www.path.ai Path.ai]: AI in Pathology. $75M+ raised. Boston. General Catalyst.
 +
*[https://www.aidoc.com/ AIDoc]: $41.5M raised. Israel. FDA cleared. Analyzes CT exams for a suspected intracranial hemorrhage, then prioritizes workflow for radiologist
 +
*[https://densitas.health/solutions Densitas]: FDA-cleared. $1.3M raised. Canadian. Assesses breast density (associated with increased risk of breast cancer)  on digital mammograms.
  
 
== Billing ==
 
== Billing ==
Line 44: Line 50:
 
*[http://www.kensci.com KenSci]: Risk stratification of patient populations using ML. UW Tacoma professor founder. $8.5M raised.
 
*[http://www.kensci.com KenSci]: Risk stratification of patient populations using ML. UW Tacoma professor founder. $8.5M raised.
 
*[http://lumiata.com/product/ Lumiata]: Healthcare risk management using AI. $20M raised. Khosla Ventures.
 
*[http://lumiata.com/product/ Lumiata]: Healthcare risk management using AI. $20M raised. Khosla Ventures.
 +
*[https://www.closedloop.ai/home/#product ClosedLoop.ai]: Seed stage
  
 
== Chatbots ==
 
== Chatbots ==
Line 52: Line 59:
 
*[http://www.orderlyhealth.com/ Orderly Health]:
 
*[http://www.orderlyhealth.com/ Orderly Health]:
 
*[https://www.botmd.io/en/ Bot MD]: $700K seed. YCombinator. Steve Blank.
 
*[https://www.botmd.io/en/ Bot MD]: $700K seed. YCombinator. Steve Blank.
 +
*[Http://www.ada.com Ada]: Germany based, funded. $69M+
  
 
== Genomics ==
 
== Genomics ==
 
*[https://www.deepgenomics.com/tech/ Deep Genomics]: Using ML to predict effects of genetic variation on a disease context. $3.7M raised. Canadian.
 
*[https://www.deepgenomics.com/tech/ Deep Genomics]: Using ML to predict effects of genetic variation on a disease context. $3.7M raised. Canadian.

Latest revision as of 09:47, 1 July 2019

Misc.

  • Cardiogram: Ex-google founders, applying deep learning to mobile health data. Backed by Andreessen Horowitz.
  • Neura: Using AI to optimize mobile apps and IoT devices for Med adherence. Interesting SDK approach. Raised $13M. Israeli team, located in Sunnyvale.
  • Enlitic: SF-based, $15M raised. Applying deep-learning to areas like triage, radiology, screening.
  • Deep6: AI-based text analysis of EHRs to find clinical trial candidates. ? Funding.
  • Digital Reasoning: Cognitive computing applied to industries. Healthcare focus. $73.9M raised.
  • PhysIQ: ML applied to biosignals to create a personal baseline. Selling to post-acute providers, pharma (clinical trials), wearable/device manufacturers. $11.9M raised.
  • DreaMed Diabetes: $5.3M raised from Medtronic. Closed-loop insulin delivery tech. CE mark for artificial pancreas.
  • Roam Analytics: ML platform for various applications in healthcare. $21M raised.
  • Hindsait: Various applications of NLP, ML in Healthcare. Unknown funding.
  • Precision Health AI: $20M Series A in 2017. Oncology treatment focus.
  • Carta: ML-based predictive models off of EHR data. Inpatient-focused. Funded by AMV.
  • Eko.ai: Stealth but something around Echocardiograms. Singapore.

Computer Vision

  • Zebra Med: AI applied to medical imaging. $20M raised. Israeli.
  • Jvion: Cognitive computing applied to clinical data to make various predictions. $9M raised.
  • AI Cure: Applying machine learning and computer vision to medication adherence. Smartphone camera can verify if the patient took medication. Raised $15M+.
  • Gauss Surgical: $24M raised. Computer vision and AI for measuring blood loss during surgery. Since 2011.
  • BayLabs: Applying deep learning to ultrasound imaging. $5.3M Series A.
  • Aidence: Medical image analysis. Amsterdam. $2.5M raised.
  • Paige.AI: Pathology AI Guidance Engine. Oncology focus. $25M Series A.
  • Qure.ai: Imaging AI
  • Viz.AI: AI-based identification of suspected large vessel occlusion (LVO) strokes. $30.6M Series A. KPCB.
  • Arterys: AI for radiology workflow. $46M raised. Has FDA approvals.
  • Brainomix: AI interpretation of brain CT scans of stroke patients. $13M raised. UK based.
  • MD.AI: Annotation tool, algorithms and datasets.
  • Path.ai: AI in Pathology. $75M+ raised. Boston. General Catalyst.
  • AIDoc: $41.5M raised. Israel. FDA cleared. Analyzes CT exams for a suspected intracranial hemorrhage, then prioritizes workflow for radiologist
  • Densitas: FDA-cleared. $1.3M raised. Canadian. Assesses breast density (associated with increased risk of breast cancer) on digital mammograms.

Billing

  • Fathom Health: Applying AI and deep learning NLP to reimbursement. Formerly TinyRx (on-demand prescription delivery service, shut down in May 2016). Raised $7.7M. Google ventures included.
  • CloudMedX: $6.7M raised. Billing optimization.

Therapy Discovery

  • Atomwise: Drug discovery using AI. Raised $6M+
  • Recursion Pharmaceuticals: Drug discovery using AI. $58M raised.
  • Benevolent.ai: AI for drug discovery and bioscience innovation in general. $140M raised. UK based.
  • GNS Healthcare: Machine learning applied for precision medicine. Solutions around patient segmentation, drug discovery. $43M raised.
  • Berg: Unknown funding. Therapy discovery using omics data.
  • Turbine: Cancer therapeutics using AI. Unknown funding. EU.
  • BioAge Labs Drug discovery related to aging. $10.9M Series A led by A16Z.
  • Qrativ: AI platform to identify treatments for rare diseases. $8.5M. Mayo Clinic.
  • Engine Bio: $10M Seed in Jan 2018.
  • Insitro: Founder is Stanford's Daphne Koller
  • Verge Genomics: $32M. DFJ.

Risk Stratification

  • KenSci: Risk stratification of patient populations using ML. UW Tacoma professor founder. $8.5M raised.
  • Lumiata: Healthcare risk management using AI. $20M raised. Khosla Ventures.
  • ClosedLoop.ai: Seed stage

Chatbots

  • Your MD: AI-driven chatbot that does lead gen for care services. $7.3M funded. London based.
  • Buoy: $2M raised. Adam Grant (Author) is founder.
  • Babylon Health: $25M raised. UK.
  • Elth: India-based
  • Orderly Health:
  • Bot MD: $700K seed. YCombinator. Steve Blank.
  • Ada: Germany based, funded. $69M+

Genomics

  • Deep Genomics: Using ML to predict effects of genetic variation on a disease context. $3.7M raised. Canadian.